当前位置: X-MOL 学术Bone Joint Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tibial bone and soft-tissue concentrations following combination therapy with vancomycin and meropenem - evaluated by microdialysis in a porcine model : should patients with open fractures have higher doses of antibiotics?
Bone & Joint Research ( IF 4.7 ) Pub Date : 2022-2-19 , DOI: 10.1302/2046-3758.112.bjr-2021-0321.r1
Sofus Ørbæk Vittrup 1, 2 , Pelle Hanberg 1, 2 , Martin Bruun Knudsen 1 , Sara Kousgaard Tøstesen 1, 2 , Josephine Olsen Kipp 1, 2 , Jakob Hansen 3 , Nis Pedersen Jørgensen 4 , Maiken Stilling 1, 2, 5 , Mats Bue 1, 2, 5
Affiliation  

Prompt and sufficient broad-spectrum empirical antibiotic treatment is key to preventing infection following open tibial fractures. Succeeding co-administration, we dynamically assessed the time for which vancomycin and meropenem concentrations were above relevant epidemiological cut-off (ECOFF) minimal inhibitory concentrations (T > MIC) in tibial compartments for the bacteria most frequently encountered in open fractures. Low and high MIC targets were applied: 1 and 4 µg/ml for vancomycin, and 0.125 and 2 µg/ml for meropenem.

中文翻译:

万古霉素和美罗培南联合治疗后胫骨和软组织浓度——通过猪模型中的微透析评估:开放性骨折患者是否应该使用更高剂量的抗生素?

及时和充分的广谱经验性抗生素治疗是预防开放性胫骨骨折后感染的关键。成功共同给药后,我们动态评估了胫骨隔室中万古霉素和美罗培南浓度高于开放性骨折中最常遇到的细菌的相关流行病学临界值 (ECOFF) 最小抑制浓度 (T > MIC) 的时间。应用了低和高 MIC 目标:万古霉素 1 和 4 µg/ml,美罗培南 0.125 和 2 µg/ml。
更新日期:2022-02-19
down
wechat
bug